+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Cell-based Assays Market Size, Share & Industry Trends Analysis Report by Application (Drug Discovery, Basic Research and Others), End-user, Products & Services, Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 87 Pages
  • October 2022
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5694718
The Asia Pacific Cell-based Assays Market should witness market growth of 9.0% CAGR during the forecast period (2022-2028).

ROS stands for reactive oxygen species, which refers to oxygen-containing molecules that exhibit chemical reactivity. ROS assays can be employed to screen chemical compounds, determine the effects of certain species on mammalian cells, and gain a better understanding of these effects. One of the most important distinctions between cell-based assays and biochemical assays is that cell-based ROS as well as oxidative stress assays offer biologically relevant data to evaluate cell viability, proliferation, or cytotoxicity.

This is in contrast to biochemical assays, which measure the binding or activity of biological molecules. Protein concentration can be measured using different types of protein assays. The enzyme-linked immunosorbent assay, which is used to determine and quantify soluble substances for medical testing and quality control, and the MTT assay, which is used to quantify cellular metabolic activity as an indicator of cell viability, proliferation, and cytotoxicity, are both examples of common protein assays.

It is essential to consider the development and deployment of translational phenotypic assays in addition to the deciphering of various molecular mechanisms of action for novel molecular entities if one aims to limit the amount of attrition that occurs during the drug development process. Through a method that is now known as high-content screening, high-throughput fluorescence as well as confocal microscopes with advanced analytical software have made it easier to simultaneously identify and quantify a wide variety of cellular processes. This method was formerly known as high-content imaging (HCS).

The Indian pharmaceutical industry, with a wide prevalence of several key market players, is expanding at an exponential rate. In the early 1990s, India announced that it had signed an agreement with the World Trade Organization that would begin implementing a product patent system in 2005. This announcement marked the beginning of Indian pharmaceutical companies' entry into the field of drug discovery and development. Alterations to the regulatory environment in the same year led to other developments, such as the emergence of the country as a favourite destination for chemistry outsourcing, followed by collaborative drug discovery as contract authorities where in-house capabilities in the chemistry of local companies were augmented with focus biology.

The China market dominated the Asia Pacific Cell-based Assays Market by Country in 2021; thereby, achieving a market value of $1.8 billion by 2028. The Japan market is registering CAGR of 8.4% during (2022-2028). Additionally, The India market would showcase a CAGR of 9.7% during (2022-2028).

Based on Application, the market is segmented into Drug Discovery, Basic Research and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Contract Research Organizations (CROs). Based on Products & Services, the market is segmented into Assay Kits, Reagents, Microplates, Probes & Labels, Instruments & Software and Cell Lines. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Incorporated, Charles River Laboratories International, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Lonza Group AG, Merck Group, Promega Corporation and Thermo Fisher Scientific, Inc.

Scope of the Study

By Application

  • Drug Discovery
  • Basic Research
  • Others

By End-user

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

By Products & Services

  • Assay Kits
  • Reagents
  • Microplates
  • Probes & Labels
  • Instruments & Software
  • Cell Lines

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Corning Incorporated
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Lonza Group AG
  • Merck Group
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Cell-based Assays Market, by Application
1.4.2 Asia Pacific Cell-based Assays Market, by End-user
1.4.3 Asia Pacific Cell-based Assays Market, by Products & Services
1.4.4 Asia Pacific Cell-based Assays Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 The Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun - 2021, Jun) Leading Players
Chapter 4. Asia Pacific Cell-based Assays Market by Application
4.1 Asia Pacific Drug Discovery Market by Country
4.2 Asia Pacific Basic Research Market by Country
4.3 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Cell-based Assays Market by End-use
5.1 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
5.2 Asia Pacific Academic & Research Institutes Market by Country
5.3 Asia Pacific Contract Research Organizations (CROs) Market by Country
Chapter 6. Asia Pacific Cell-based Assays Market by Products & Services
6.1 Asia Pacific Assay Kits Market by Country
6.2 Asia Pacific Reagents Market by Country
6.3 Asia Pacific Microplates Market by Country
6.4 Asia Pacific Probes & Labels Market by Country
6.5 Asia Pacific Instruments & Software Market by Country
6.6 Asia Pacific Cell Lines Market by Country
Chapter 7. Asia Pacific Cell-based Assays Market by Country
7.1 China Cell-based Assays Market
7.1.1 China Cell-based Assays Market by Application
7.1.2 China Cell-based Assays Market by End-use
7.1.3 China Cell-based Assays Market by Products & Services
7.2 Japan Cell-based Assays Market
7.2.1 Japan Cell-based Assays Market by Application
7.2.2 Japan Cell-based Assays Market by End-use
7.2.3 Japan Cell-based Assays Market by Products & Services
7.3 India Cell-based Assays Market
7.3.1 India Cell-based Assays Market by Application
7.3.2 India Cell-based Assays Market by End-use
7.3.3 India Cell-based Assays Market by Products & Services
7.4 South Korea Cell-based Assays Market
7.4.1 South Korea Cell-based Assays Market by Application
7.4.2 South Korea Cell-based Assays Market by End-use
7.4.3 South Korea Cell-based Assays Market by Products & Services
7.5 Singapore Cell-based Assays Market
7.5.1 Singapore Cell-based Assays Market by Application
7.5.2 Singapore Cell-based Assays Market by End-use
7.5.3 Singapore Cell-based Assays Market by Products & Services
7.6 Malaysia Cell-based Assays Market
7.6.1 Malaysia Cell-based Assays Market by Application
7.6.2 Malaysia Cell-based Assays Market by End-use
7.6.3 Malaysia Cell-based Assays Market by Products & Services
7.7 Rest of Asia Pacific Cell-based Assays Market
7.7.1 Rest of Asia Pacific Cell-based Assays Market by Application
7.7.2 Rest of Asia Pacific Cell-based Assays Market by End-use
7.7.3 Rest of Asia Pacific Cell-based Assays Market by Products & Services
Chapter 8. Company Profiles
8.1 Becton, Dickinson and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent Strategies and Developments
8.1.5.1 Partnerships, Collaborations, and Agreements
8.1.5.2 Product Launches and Product Expansions
8.1.5.3 Acquisition and Mergers
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent Strategies and Developments
8.2.5.1 Partnerships, Collaborations, and Agreements
8.2.5.2 Product Launches and Product Expansions
8.2.5.3 Acquisition and Mergers
8.2.5.4 Approvals and Trials
8.3 Thermo Fisher Scientific, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent Strategies and Developments
8.3.5.1 Partnerships, Collaborations, and Agreements
8.3.5.2 Geographical Expansions
8.4 Bio-Rad laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent Strategies and Developments
8.4.5.1 Partnerships, Collaborations, and Agreements
8.4.5.2 Acquisition and Mergers
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent Strategies and Developments
8.5.4.1 Partnerships, Collaborations, and Agreements
8.5.4.2 Acquisition and Mergers
8.6 Danaher Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent Strategies and Developments
8.6.5.1 Product Launches and Product Expansions
8.7 Merck Group
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent Strategies and Developments
8.7.5.1 Partnerships, Collaborations, and Agreements
8.8 Lonza Group AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent Strategies and Developments
8.8.5.1 Partnerships, Collaborations, and Agreements
8.9 Corning Incorporated
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent Strategies and Developments
8.9.5.1 Product Launches and Product Expansions
8.10. Promega Corporation
8.10.1 Company Overview
8.10.2 Recent Strategies and Developments
8.10.2.1 Partnerships, Collaborations, and Agreements
8.10.2.2 Product Launches and Product Expansions

Companies Mentioned

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Corning Incorporated
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Lonza Group AG
  • Merck Group
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...